Clinical Outcomes Following Empiric Radioiodine Therapy in Patients with Structurally Identifiable Metastatic Follicular Cell–Derived Thyroid Carcinoma with Negative Diagnostic But Positive Post-Therapy 131I Whole-Body Scans-Reference-Cited by-同舟云学术

Clinical Outcomes Following Empiric Radioiodine Therapy in Patients with Structurally Identifiable Metastatic Follicular Cell–Derived Thyroid Carcinoma with Negative Diagnostic But Positive Post-Therapy 131I Whole-Body Scans

Published:2012-09 Issue:9 Volume:22 Page:877-883
ISSN:1050-7256
Container-title:Thyroid
language:en
Short-container-title:Thyroid

Author:

Sabra Mona M.¹,Grewal Ravinder K.²,Tala Hernan³,Larson Steve M.²,Tuttle R. Michael¹

Affiliation:

1. Endocrinology Service, Department of Medicine, Memorial Sloan-Kettering Cancer Center, New York, New York.

2. Nuclear Medicine Service, Department of Radiology, Memorial Sloan-Kettering Cancer Center, New York, New York.

3. Alemana Clinic, Father Hurtado Hospital, Santiago, Chile.

Publisher

Mary Ann Liebert Inc

Subject

Endocrinology,Endocrinology, Diabetes and Metabolism

Link

https://www.liebertpub.com/doi/pdf/10.1089/thy.2011.0429

Reference21 articles.

1. Nuclear Imaging in the Management of Thyroid Carcinoma

2. Treating the patient with differentiated thyroid cancer with thyroglobulin-positive iodine-131 diagnostic scan-negative metastases: Including comments on the role of serum thyroglobulin monitoring in tumor surveillance

3. Clinical utility of posttreatment radioiodine scans in the management of patients with thyroid carcinoma

4. Value of stimulated serum thyroglobulin levels for detecting persistent or recurrent differentiated thyroid cancer in high- and low-risk patients

5. Serum and tissue thyroglobulin measurement: Clinical applications in thyroid disease

Cited by 50 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Match Point: Nuclear Medicine Imaging for Recurrent Thyroid Cancer in TENIS Syndrome—Systematic Review and Meta-Analysis;Journal of Clinical Medicine;2024-09-10

2. Korean Thyroid Association Guidelines on the Management of Differentiated Thyroid Cancers; Part III. Management of Advanced Differentiated Thyroid Cancers - Chapter 4. Systemic Therapy for Progressive Radioiodine-Refractory Differentiated Thyroid Cancer 2024;International Journal of Thyroidology;2024-05-30

3. Efficacy of Empirical Radioiodine Therapy in Patients with Differentiated Thyroid Cancer and Elevated Serum Thyroglobulin without Evidence of Structural Disease: A Propensity Score Analysis;Cancers;2023-08-21

4. Leukemic Involvement Is a Common Feature in Waldenström Macroglobulinemia at Diagnosis;Cancers;2023-08-17

5. A Phase II Redifferentiation Trial with Dabrafenib-Trametinib and 131I in Metastatic Radioactive Iodine Refractory BRAF p.V600E-Mutated Differentiated Thyroid Cancer;Clinical Cancer Research;2023-04-19